Interpharm Holdings Stock Market Value
| IPAH Stock | USD 0 0.00 0.00% |
| Symbol | Interpharm |
Is there potential for Pharmaceuticals market expansion? Will Interpharm introduce new products? Factors like these will boost the valuation of Interpharm Holdings. Market participants price Interpharm higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Interpharm Holdings' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Interpharm Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Interpharm Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Interpharm Holdings.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Interpharm Holdings on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Interpharm Holdings or generate 0.0% return on investment in Interpharm Holdings over 90 days. Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmac... More
Interpharm Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Interpharm Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Interpharm Holdings upside and downside potential and time the market with a certain degree of confidence.
Interpharm Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Interpharm Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Interpharm Holdings' standard deviation. In reality, there are many statistical measures that can use Interpharm Holdings historical prices to predict the future Interpharm Holdings' volatility.Interpharm Holdings Backtested Returns
We have found three technical indicators for Interpharm Holdings, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Interpharm Holdings are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Interpharm Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between Interpharm Holdings time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Interpharm Holdings price movement. The serial correlation of 0.0 indicates that just 0.0% of current Interpharm Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out Interpharm Holdings Correlation, Interpharm Holdings Volatility and Interpharm Holdings Performance module to complement your research on Interpharm Holdings. For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Interpharm Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.